Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ATOS holding history

Atossa Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ATOS overviewAll 13F holders of ATOSFull Q2 2026 holdings

Shares (Q2 2026)
132,043
Value
$254.8K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ATOS by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026132,043$254.8K<0.1%+23,036+21.1%AddedHolders
Q1 2026109,007$573.4K<0.1%−28,516−20.7%ReducedConverted for a 1-for-15 splitHolders
Q4 20252,062,838$1.22M<0.1%+514,175+33.2%AddedHolders
Q3 20251,548,663$1.34M<0.1%−263,588−14.5%ReducedHolders
Q2 20251,812,251$1.50M<0.1%−42,850−2.3%ReducedHolders
Q1 20251,855,101$1.25M<0.1%+297,469+19.1%AddedHolders
Q4 20241,557,632$1.47M<0.1%+247,562+18.9%AddedHolders
Q3 20241,310,070$1.99M<0.1%−240,840−15.5%ReducedHolders
Q2 20241,550,910$1.85M<0.1%+164,540+11.9%AddedHolders
Q1 20241,386,370$2.50M<0.1%+102,100+8.0%AddedHolders
Q4 20231,284,270$1.13M<0.1%+41,900+3.4%AddedHolders
Q3 20231,242,370$915.0K<0.1%+168,300+15.7%AddedHolders
Q2 20231,074,070$1.35M<0.1%+138,000+14.7%AddedHolders
Q1 2023936,070$679.0K<0.1%+91,300+10.8%AddedHolders
Q4 2022844,770$446.0K<0.1%−250,940−22.9%ReducedHolders
Q3 20221,095,710$913.0K<0.1%−894,285−44.9%ReducedHolders
Q2 20221,989,995$2.17M<0.1%−110,497−5.3%ReducedHolders
Q1 20222,100,492$2.63M<0.1%+930,152+79.5%AddedHolders
Q4 20211,170,340$1.87M<0.1%+1,170,340NewHolders
Q2 20210$00.0%−3,304,140−100.0%Sold outHolders
Q1 20213,304,140$6.97M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.